Wellgistics Health, Inc. (NASDAQ:WGRX) completed a strategic investment in a San Francisco‑based mental‑health artificial‑intelligence startup on February 18, 2026. The investment is part of the company’s plan to broaden its EinsteinRx AI platform and PharmacyChain blockchain initiatives into the growing mental‑health software market, which is projected to reach $18.1 billion by 2033.
The startup, whose name has not yet been disclosed, is preparing to launch its service after successful beta testing. The investment will allow Wellgistics to integrate the startup’s AI‑driven patient engagement tools with its existing telehealth partnership with Tollo Health’s TolloCare, creating a more comprehensive digital‑health ecosystem for independent pharmacies.
Wellgistics has been pursuing a strategic pivot from a traditional pharmaceutical distribution model to a patient‑centric digital‑health platform. The company’s recent financial results show a weak gross‑profit margin of 7.86 % and short‑term obligations that exceed liquid assets, underscoring the urgency of the investment to generate new revenue streams and improve profitability.
The mental‑health software market is expected to grow from $6.3 billion in 2025 to $18.1 billion by 2033, according to industry estimates. By entering this market, Wellgistics aims to capture a share of the expanding demand for AI‑enabled mental‑health solutions, particularly in the context of rising prescription rates for GLP‑1 drugs used for diabetes and obesity.
While the company’s stock has traded near its 52‑week low, the investment signals management’s confidence in the long‑term value of digital‑health integration. The move is expected to enhance patient engagement and medication adherence for GLP‑1 prescriptions, potentially driving higher utilization of Wellgistics’ pharmacy‑chain services.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.